Veracyte And 2 More Stocks That Might Be Trading Below Their Estimated Value

Simply Wall St.
04-11

Amid recent market volatility, with major indices like the Dow Jones and Nasdaq experiencing significant declines, investors are increasingly on the lookout for stocks that may be trading below their intrinsic value. In such turbulent times, identifying undervalued stocks can offer potential opportunities as these equities might not fully reflect their companies' fundamental strengths or future prospects.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name Current Price Fair Value (Est) Discount (Est)
CareTrust REIT $(CTRE)$ $27.41 $54.76 49.9%
NBT Bancorp (NasdaqGS:NBTB) $40.45 $78.70 48.6%
Semrush Holdings $(SEMR)$ $9.14 $18.17 49.7%
First Reliance Bancshares (OTCPK:FSRL) $9.35 $18.55 49.6%
Vericel (NasdaqGM:VCEL) $44.24 $86.05 48.6%
Veracyte (NasdaqGM:VCYT) $32.62 $64.53 49.4%
Elastic $(ESTC)$ $83.35 $163.03 48.9%
Zillow Group (NasdaqGS:ZG) $64.96 $128.27 49.4%
BioLife Solutions (NasdaqCM:BLFS) $22.79 $44.51 48.8%
CNX Resources $(CNX)$ $29.35 $57.33 48.8%

Click here to see the full list of 183 stocks from our Undervalued US Stocks Based On Cash Flows screener.

Here's a peek at a few of the choices from the screener.

Veracyte

Overview: Veracyte, Inc. is a diagnostics company operating in the United States and internationally, with a market cap of approximately $2.25 billion.

Operations: The company generates revenue from its diagnostic products, amounting to $445.76 million.

Estimated Discount To Fair Value: 49.4%

Veracyte, Inc. is trading significantly below its estimated fair value, with a price of US$32.62 against a fair value estimate of US$64.53, indicating potential undervaluation based on cash flows. The company has recently become profitable with net income reaching US$24.14 million in 2024 compared to a loss the previous year. Veracyte's innovative MRD testing platform shows promising clinical performance, potentially enhancing future revenue streams and supporting its growth trajectory in the oncology diagnostics market.

  • Insights from our recent growth report point to a promising forecast for Veracyte's business outlook.
  • Dive into the specifics of Veracyte here with our thorough financial health report.
NasdaqGM:VCYT Discounted Cash Flow as at Apr 2025

Bentley Systems

Overview: Bentley Systems, Incorporated develops and provides infrastructure engineering software solutions globally, with a market capitalization of approximately $12.20 billion.

Operations: The company's revenue is primarily derived from its Computer Software and Related Services segment, totaling $1.35 billion.

Estimated Discount To Fair Value: 10.2%

Bentley Systems is trading slightly below its estimated fair value of US$46.96, with a current price of US$42.15, suggesting some undervaluation based on cash flows. Recent earnings show revenue growth to US$1.35 billion in 2024, but net income declined to US$234.79 million from the previous year. The company completed a share buyback worth US$92.57 million and expects revenue growth to outpace the broader U.S. market in 2025 despite high debt levels.

  • Our growth report here indicates Bentley Systems may be poised for an improving outlook.
  • Click here to discover the nuances of Bentley Systems with our detailed financial health report.
NasdaqGS:BSY Discounted Cash Flow as at Apr 2025

CCC Intelligent Solutions Holdings

Overview: CCC Intelligent Solutions Holdings Inc. is a software as a service (SaaS) company serving the property and casualty insurance sectors in the United States and China, with a market cap of approximately $5.44 billion.

Operations: The company's revenue is primarily derived from its Software & Programming segment, which generated $944.80 million.

Estimated Discount To Fair Value: 21.6%

CCC Intelligent Solutions Holdings trades at US$9.02, below its estimated fair value of US$11.51, indicating undervaluation based on cash flows. The company forecasts significant earnings growth of 66.81% annually, outpacing the U.S. market's 13.5%. Recent financials show revenue reaching US$944.8 million in 2024, with a net income turnaround to US$26.15 million from a prior loss. The firm is actively pursuing M&A opportunities to bolster strategic growth and has completed a follow-on equity offering worth US$433.65 million.

  • The growth report we've compiled suggests that CCC Intelligent Solutions Holdings' future prospects could be on the up.
  • Unlock comprehensive insights into our analysis of CCC Intelligent Solutions Holdings stock in this financial health report.
NasdaqGS:CCCS Discounted Cash Flow as at Apr 2025

Turning Ideas Into Actions

  • Delve into our full catalog of 183 Undervalued US Stocks Based On Cash Flows here.
  • Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
  • Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.

Looking For Alternative Opportunities?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
  • Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NasdaqGM:VCYT NasdaqGS:BSY and NasdaqGS:CCCS.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10